Evidence map›Paper›PMID 28727835›Full record

ArticlePloS one2017

Conflicting relationship between age-dependent disorders, valvular heart disease and coronary artery disease by covariance structure analysis: Possible contribution of natriuretic peptide.

Risa Fukumoto, Makoto Kawai, Kosuke Minai, Kazuo Ogawa, Jun Yoshida, Yasunori Inoue, Satoshi Morimoto, Toshikazu Tanaka, Tomohisa Nagoshi, Takayuki Ogawa and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Risa FukumotoDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Makoto KawaiDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-0914-9376
Kosuke MinaiDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Kazuo OgawaDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Jun YoshidaDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Yasunori InoueDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Satoshi MorimotoDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Toshikazu TanakaDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Tomohisa NagoshiDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Takayuki OgawaDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Michihiro YoshimuraDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Jikei University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is conceivable that contemporary valvular heart disease (VHD) is affected largely by an age-dependent atherosclerotic process, which is similar to that observed in coronary artery disease (CAD). However, a comorbid condition of VHD and CAD has not been precisely examined. The first objective of this study was to examine a possible comorbid condition. Provided that there is no comorbidity, the second objective was to search for the possible reasons by using conventional risk factors and plasma B-type natriuretic peptide (BNP) because BNP has a potentiality to suppress atherosclerotic development.

methodsThe study population consisted of 3,457 patients consecutively admitted to our institution. The possible comorbid condition of VHD and CAD and the factors that influence the comorbidity were examined by covariance structure analysis and multivariate analysis.

resultsThe distribution of the patients with VHD and those with CAD in the histograms showed that the incidence of VHD and the severity of CAD rose with seniority in appearance. The real statistical analysis was planned by covariance structure analysis. The current path model revealed that aging was associated with VHD and CAD severity (P < 0.001 for each); however, as a notable result, there was an inverse association regarding the comorbid condition between VHD and CAD (Correlation coefficient [β]: -0.121, P < 0.001). As the second objective, to clarify the factors leading to this inverse association, the contribution of conventional risk factors, such as age, gender, hypertension, smoking, diabetes, obesity and dyslipidemia, to VHD and CAD were examined by multivariate analysis. However, these factors did not exert an opposing effect on VHD and CAD, and the inverse association defied explanation. Since different pathological mechanisms may contribute to the formation of VHD and CAD, a differentially proposed path model using plasma BNP revealed that an increase in plasma BNP being drawn by VHD suppressed the progression of CAD (β: -0.465, P < 0.001).

conclusionsThe incidence of VHD and CAD showed a significant conflicting relationship. This result supported the likely presence of unknown diverse mechanisms on top of the common cascade of atherosclerosis. Among them, the continuous elevation of plasma BNP due to VHD might be one of the explicable factors suppressing the progression of CAD.

Indexed as

AgingAdultAgedAged, 80 and overAtherosclerosisCoronary Artery DiseaseFemaleHeart Valve DiseasesHumansIncidenceMaleMiddle AgedMultivariate AnalysisNatriuretic PeptidesNatriuretic Peptides

Identifiers

PMID28727835
PMCPMC5519065
OpenAlexW2736434028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.